Researchers analyzed population-based data of 11,864 patients diagnosed with de novo metastatic cancer in 1976 and 26,324 patients diagnosed in 2015, with follow-up through 1981 and 2020.

People who have received a cancer diagnosis are living longer than ever, according to a new report from the American Cancer Society (ACS). Decades of cancer research have led to more effective ...

Survival rates for laryngeal cancer vary, depending on whether the cancer starts in your glottis and whether it spreads to other tissues or organs. Laryngeal cancer happens when cancerous cells grow ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, side effects and when it could reach patients.

Following surgery for stage IA lung cancer, survival and quality of life were similar between patients aged 80 years and ...

A metastatic renal cell carcinoma (RCC) diagnosis can open the door to feelings of fear and uncertainty about your future. After getting the news, you may be eager for information about your options, ...

When you learn you have bladder cancer, it’s only natural to ask: "Can I survive this, for how long, and can I expect to be cured?" You may have searched online for survival rate information. These ...

Several factors can affect vaginal cancer survival rates. They include the stage and type of cancer as well as your age. Effective treatments for vaginal cancer are available, especially if it’s found ...

Investigators compared outcomes up to 15 years post-diagnosis across 6 racial/ethnic groups to identify disparities in survival.

Ovarian cancer mortality has declined, but racial and age disparities persist, with non-Hispanic White patients having the highest AAMRs. Non-Hispanic Asian or Pacific Islander populations show the ...